Association between Systemic Factors and Vitreous Fluid Cytokines in Proliferative Diabetic Retinopathy

被引:2
|
作者
Sato, Tomohito [1 ]
Okazawa, Rina [1 ]
Nagura, Koichi [1 ]
Someya, Hideaki [1 ]
Nishio, Yoshiaki [1 ]
Enoki, Toshio [2 ]
Ito, Masataka [3 ]
Takeuchi, Masaru [1 ]
机构
[1] Natl Def Med Coll, Dept Ophthalmol, 3-2 Namiki, Tokorozawa 3598513, Japan
[2] Enoki Eye Clin, Sayama 3501316, Japan
[3] Natl Def Med Coll, Dept Dev Anat & Regenerat Biol, Tokorozawa 3598513, Japan
基金
日本学术振兴会;
关键词
blood pressure; body mass index; influence; interleukin-6; monocyte chemoattractant protein-1; proliferative diabetic retinopathy; vascular endothelial growth factor; vitreous fluid cytokine; MACULAR EDEMA; INTERFERON-GAMMA; DISEASE; RISK; VEGF; TRIAMCINOLONE; INTERLEUKIN-6; ANGIOGENESIS; INFLAMMATION; PROGRESSION;
D O I
10.3390/jcm12062354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proliferative diabetic retinopathy (PDR) is a vision-threatening complication of diabetes mellitus (DM). Systemic and intraocular factors are intricately related to PDR, and vitreous fluid (VF) cytokines are representative intraocular biomarkers. However, the associations between systemic factors and VF cytokines and their influence on PDR pathology are unclear. This study aimed to examine the correlation between systemic factors and VF cytokines and analyze their contributions to the pathology of PDR using multivariate analyses. We conducted a retrospective observational study on 26 PDR eyes of 25 patients with type 2 DM, and 30 eyes of 30 patients with idiopathic macular hole or epiretinal membrane as controls. Fifteen systemic and laboratory tests including blood pressure (BP) and body mass index (BMI), and 27 cytokines in VF were analyzed. BP and BMI correlated positively with VF levels of IL-6 and IP-10 in PDR patients, while no significant correlation was found between systemic factors and VF cytokines in controls. MCP-1 and VEGF-A in VF separately clustered with different systemic factors in controls, but these cytokines lost the property similarity with systemic factors and acquired property similarity with each other in PDR. Systemic factors contributed to only 10.4%, whereas VF cytokines contributed to 42.3% out of 52.7% variance of the whole PDR dataset. Our results suggest that intraocular factors play a major role in the pathology of PDR, whereas systemic factors may have limited effects, and that BP and BMI control in PDR could be useful interventions to improve intraocular immune condition.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Immunoreactive endothelin levels in the vitreous fluid are decreased in diabetic patients with proliferative retinopathy
    Ogata, M
    Naruse, M
    Iwasaki, N
    Katoh, S
    Ohta, Y
    Hori, S
    Demura, H
    Iwamoto, Y
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S378 - S379
  • [32] IGF-I OF SERUM AND VITREOUS FLUID IN PATIENTS WITH DIABETIC PROLIFERATIVE RETINOPATHY
    LEE, HC
    LEE, KW
    CHUNG, CH
    CHUNG, YS
    LEE, EJ
    LIM, SK
    KIM, KR
    HUH, KB
    LEE, SC
    KWON, OW
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 24 (02) : 85 - 88
  • [33] Evaluation of Vitreous Factor in Proliferative Diabetic Retinopathy
    Nandakumar, Namrata
    Teague, Gianna C.
    Lopez, Francisco J.
    Johnson, Walter
    Lashkari, Kameran
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [34] Characterisation of the vitreous proteome in proliferative diabetic retinopathy
    Wang, Hao
    Feng, Le
    Hu, Jian Wen
    Xie, Chun Lei
    Wang, Fang
    PROTEOME SCIENCE, 2012, 10
  • [35] Characterisation of the vitreous proteome in proliferative diabetic retinopathy
    Hao Wang
    Le Feng
    Jian Wen Hu
    Chun Lei Xie
    Fang Wang
    Proteome Science, 10
  • [36] Vitreous metabolomics profiling of proliferative diabetic retinopathy
    Tomita, Yohei
    Cagnone, Gael
    Fu, Zhongjie
    Cakir, Bertan
    Kotoda, Yumi
    Asakage, Masaki
    Wakabayashi, Yoshihiro
    Hellstrom, Ann
    Joyal, Jean-Sebastien
    Talukdar, Saswata
    Smith, Lois E. H.
    Usui, Yoshihiko
    DIABETOLOGIA, 2021, 64 (01) : 70 - 82
  • [37] VITREOUS SURGERY FOR PROLIFERATIVE DIABETIC-RETINOPATHY
    MICHELS, RG
    INTERNATIONAL OPHTHALMOLOGY, 1985, 8 (02) : 103 - 103
  • [38] Evaluation of osteopontin in the vitreous of proliferative diabetic retinopathy
    Nagura, Koichi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [39] Vitreous metabolomics profiling of proliferative diabetic retinopathy
    Yohei Tomita
    Gael Cagnone
    Zhongjie Fu
    Bertan Cakir
    Yumi Kotoda
    Masaki Asakage
    Yoshihiro Wakabayashi
    Ann Hellström
    Jean-Sébastien Joyal
    Saswata Talukdar
    Lois E. H. Smith
    Yoshihiko Usui
    Diabetologia, 2021, 64 : 70 - 82
  • [40] CYTOKINES IN PROLIFERATIVE DIABETIC-RETINOPATHY AND PROLIFERATIVE VITREORETINOPATHY
    ELNER, SG
    ELNER, VM
    JAFFE, GJ
    STUART, A
    KUNKEL, SL
    STRIETER, RM
    CURRENT EYE RESEARCH, 1995, 14 (11) : 1045 - 1053